脑动静脉畸形出血后的临床结局
在383例伽玛刀术后至畸形团闭塞前发生症状性出血的患者中研究临床结局,21%死亡、45%出现或加重神经后遗症、35%完全恢复,高龄为不良结局预测因素,治疗参数与结局无关,提示结果也适用于未治疗者。
要点
- 脑动静脉畸形破裂后约20%死亡、45%遗留轻或重度功能障碍、35%完全恢复。
- 高龄是不良结局的预测因素,性别、畸形团位置、体积及既往出血史不影响结局。
- 死亡率与既往前瞻性数据相当,但高于回顾性研究,提示回顾性研究低估死亡风险。
核心结论
- 既往回顾性系列及聚焦脑动静脉畸形出血后临床结局的研究显著低估了出血后死亡结局的风险。
- 基于本研究,脑动静脉畸形破裂约20%可能致死、45%可能遗留轻度或重度功能障碍、35%可能完全恢复,该发现可能也适用于一般脑动静脉畸形破裂。
- 诊断后25年,未闭塞脑动静脉畸形患者的累积死亡与致病率估计约为40%。
研究设计与样本
- 研究纳入383例在伽玛刀®手术后、确认畸形团闭塞前发生症状性出血的患者,为迄今研究的最多患者人群。
- 分析不同患者、畸形团及治疗参数对临床结局的影响,旨在通过与既往发表结果比较并结合数据生成结局预测。
主要发现
- 21%的患者死亡,45%出现或经历神经后遗症加重,35%在出血后完全恢复。
- 高龄是不良结局的预测因素。
- 性别、畸形团位置、畸形团体积及既往出血史不影响结局。
- 临床结局与治疗参数之间无关系,提示结果也适用于未治疗的脑动静脉畸形。
- 死亡率与既往发表的前瞻性数据相当,但高于回顾性研究中的死亡率。
关键数值与推荐
- 脑动静脉畸形破裂后死亡可能性约20%,遗留轻度或重度功能障碍可能性约45%,完全恢复可能性约35%。
- 诊断后25年,未闭塞脑动静脉畸形患者的累积死亡与致病率估计约为40%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A significant difference exists between the published results reporting the clinical outcome following brain arteriovenous malformation (AVM) ruptures. Information about the outcome following hemorrhage in an AVM population treated with radiosurgery could provide additional information to assess the risk of mortality and morbidity following an AVM hemorrhage. METHODS: Clinical outcome was studied in 383 patients, the largest patient population yet studied, who suffered from a symptomatic hemorrhage after Gamma Knife® surgery (GKS) but before confirmed AVM obliteration. The impact of different patient, AVM, and treatment parameters on the clinical outcome was analyzed. The aim was to generate outcome predictions by comparing our data to and combining them with earlier published results. RESULTS: No relation was found between clinical outcome and treatment parameters, indicating that the results are applicable also on untreated AVMs. Twenty-one percent of the patients died, 45% developed or experienced worsening of neurological sequelae, and 35% recovered completely after the hemorrhage. Old age was a predictor of poor outcome. Sex, AVM location, AVM volume, and history of prior hemorrhage did not influence the outcome. The mortality rate was comparable to earlier published prospective data, but higher than that found in retrospective studies. CONCLUSIONS: The mortality rates in earlier published retrospective series as well as in studies focusing on clinical outcome following AVM hemorrhage significantly underestimate the risk for a mortal outcome following an AVM hemorrhage. Based on our findings, an AVM rupture has around 20% likelihood to result in mortality, 45% likelihood to result in a minor or major deficit, and 35% likelihood of complete recovery. The findings are probably applicable also for AVM ruptures in general. The cumulative mortality and morbidity rates 25 years after diagnosis were estimated to be around 40% in a patient with a patent AVM.
引用
- Karlsson B, Jokura H, Yang HC, et al. Clinical outcome following cerebral AVM hemorrhage. Acta Neurochir (Wien). 2020. PMID: 32385636. doi:10.1007/s00701-020-04380-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。